76 results
8-K
FBRX
Forte Biosciences Inc
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
responsibility, to provide additional incentive to employees, directors and consultants, and to promote the success of the Company’s business. These purposes
8-K
EX-10.1
ewvd a4vpz
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
DFAN14A
icgaewg7oa7
14 Sep 23
Additional proxy materials by non-management
4:00pm
424B3
so0bojdh7okivrycyair
8 Sep 23
Prospectus supplement
4:36pm
DFAN14A
n5l70hq9d eyx0gnh
6 Sep 23
Additional proxy materials by non-management
4:31pm
DEFC14A
c5lldcc8dyuegimb
24 Aug 23
Proxy in contested solicitation
6:15am
PREC14A
3b0yai
2 Aug 23
Preliminary proxy with contested solicitation
5:28pm
8-K
auig 2vnnv
14 Nov 22
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
4:05pm
424B5
ahb7rs mq
12 Aug 22
Prospectus supplement for primary offering
4:46pm
8-K
EX-4.1
8x0ti9l ef
12 Jul 22
Entry into a Material Definitive Agreement
9:12am
8-K
EX-10.1
qoap74q
31 Mar 22
Entry into a Material Definitive Agreement
8:57pm